Holland & Barrett still at till with LBO financing

All eyes in the leveraged loan market this week were trained on UK health food retailer Holland & Barrett.

  • By Max Bower
  • 10 Aug 2017


The firm has shifted some £100m-equivalent from a £550m term loan to a €275m-equivalent term loan, widening pricing and extending the commitments deadline in the process.

Investors had voiced concern over the aggressive nature of the deal — leverage stands at more than 5.5 times Ebitda — and ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 14 Aug 2017
1 JPMorgan 13,737.58 53 6.79%
2 BNP Paribas 13,423.05 69 6.63%
3 Goldman Sachs 11,651.64 43 5.76%
4 Deutsche Bank 10,773.25 59 5.32%
5 Bank of America Merrill Lynch 10,450.47 41 5.16%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 15 Aug 2017
1 JPMorgan 5,262.65 41 8.27%
2 Goldman Sachs 4,580.64 36 7.20%
3 Deutsche Bank 4,249.17 39 6.67%
4 Barclays 3,956.08 33 6.21%
5 Credit Suisse 3,928.87 43 6.17%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 15 Aug 2017
1 JPMorgan 24,048.19 185 10.98%
2 Citi 19,193.03 146 8.76%
3 Bank of America Merrill Lynch 17,906.11 157 8.17%
4 Goldman Sachs 15,915.08 114 7.27%
5 Barclays 15,416.88 101 7.04%